KLK3 and posterior cortical atrophy: Gandaglia et al. [32] developed a multivariable model using patients' PSA levels, clinical stage, biopsy grade group, number of positive cores, and PSA density to assess the risk of poor outcomes in low-risk or intermediate-risk PCa patients, aiding in the selection of AS candidates.